Total raised
$42.5M
Last: Undisclosed 2024-07
Stage
Series D
Founded
2009
Headcount
33
HQ
Pardes Hanna-Karkur
Sector
Health Tech & Life Sciences
About
RedDress is the developer of ActiGraft, an FDA-cleared regenerative wound care solution based on the companys proprietary patented technology for reproducing the bodys natural ability to heal wounds. ActiGraft enables healthcare providers to produce, in real-time, in vitro blood clots from a patients whole blood. Once applied, the blood clots serve as a protective covering, biologic scaffold, and wound microenvironment to help promote the bodys natural wound-healing processes.
Funding history · 3 rounds · $42.5M total
2024-07
Undisclosed
Undisclosed
2023-05
Series D
$26.0M
2020-05
Undisclosed
$11.5M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2BB2C
Highlights
1 Patents
Tags
pain-reliefhealthcare-providersdiabeteschronic-painmedical-devicesregenerative-medicinemedical-technologies